Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
Posted inIOncology

Advancing Treatment in #TripleNegativeBreastCancer : Insights from the Keynote 522 Trial

Posted by By Peter W. PENG 2024.10.14Posted inIOncology0 Shares
Home » Advancing Treatment in #TripleNegativeBreastCancer : Insights from the Keynote 522 Trial
YouTube player
Post Views: 993

Share via:

  • Facebook
  • X (Twitter)
  • LinkedIn
  • More
Last updated on 2024.10.14
Peter W. PENG
View All Posts

Post navigation

Previous Post
AIDS Exclusive Interview | AMP Trial: Successes and Breakthroughs in HIV Prevention AIDS Exclusive Interview | AMP Trial: Successes and Breakthroughs in HIV Prevention
Next Post
Dr. Lorenza Rimassa: The 5-year OS update of the HIMALAYA study sets a new high for survival in first-line treatment of advanced liver cancer Dr. Lorenza Rimassa: The 5-year OS update of the HIMALAYA study sets a new high for survival in first-line treatment of advanced liver cancer
  • LinkedIn
  • Twitter
  • Mail
Related Media:
Copyright 2025 — MediaMedic. All rights reserved. Blogun WordPress Theme
Media Medic Publishing Company Limited(HK)
赛美出版有限公司（香港）
Scroll to Top
  • Facebook
  • X (Twitter)
  • LinkedIn
  • More Networks
Share via
Facebook
X (Twitter)
LinkedIn
Mix
Email
Print
Copy Link
Copy link
CopyCopied